The Japanese pharmaceutical industry, a vital component of global innovation, faces a talent gap that resonates across multinational corporations. While Japan possesses a wealth of highly skilled professionals, a notable communication disparity impedes recruitment and career advancement, particularly in global…
HOME > LATEST
LATEST
-
ORGANIZATION Revamp Drug Price System to Make Room for Wage Hikes: Labor Union
May 29, 2025
-
BUSINESS Kowa to Launch Japan PIII for Nicox-Partnered Glaucoma Drug
May 29, 2025
-
REGULATORY LDP Fiscal Reform HQ’s Proposal Keeps Budget Ceiling Intact, but Urges Action on Wage Front
May 28, 2025
-
REGULATORY Tap Consumption Tax Revenue to Ensure Stable Generic Supply: LDP League
May 28, 2025
-
REGULATORY LDP Group Renews Call for Addition of MCI Screening to Health Checkups
May 28, 2025
-
BUSINESS China Approves Eisai’s Insomnia Med Dayvigo
May 28, 2025
-
BUSINESS Boehringer’s Japan Pharma Biz Grows 6 Years Running on Jardiance
May 28, 2025
-
BUSINESS ALS Drug Radicava Now Available in Australia: Mitsubishi
May 28, 2025
-
BUSINESS Renascience to Welcome Former MHLW Director as EVP
May 28, 2025
-
REGULATORY MOF Panel Again Presses for Expansion of CEA Scheme: “Spring” Proposal
May 27, 2025
-
ACADEMIA Taking on Solid Tumors - 1: Japan Sees Rush of Bispecific Approvals with Good Progress in Blood Cancers, and More
May 27, 2025
-
REGULATORY Honebuto Outline Includes “Raise in Official Prices,” but Details Yet Unknown
May 27, 2025
-
BUSINESS Lilly/NCNP Tie Up for Research on APOE Gene Testing
May 27, 2025
-
BUSINESS Decline of Obesity Population Might Curb Rise in Healthcare Costs: Lilly
May 27, 2025
-
REGULATORY Japan Govt Plans Consortium for Driving Domestic Production of Radioisotopes
May 27, 2025
-
BUSINESS Mitsubishi Tanabe Taps Moderna’s Nagayama as New EVP Post
May 27, 2025
-
ORGANIZATION JPMA Revises Definition of Promotion in Code of Practice
May 27, 2025
-
REGULATORY Topic of OTC-Like Drugs Dropped from 3-Party Talks: Ishin
May 27, 2025
-
BUSINESS Moderna Launches Prefilled Version of Spikevax in Japan
May 27, 2025
-
COMMENTARY Next Wave of ALS Drugs Emerging as Novartis, Nipro Enter Development Fray
May 27, 2025
ページ
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…